ArticleJournal of translational medicine2026
Ginsenoside RG3 and cantharidin synergistically suppress the progression of hepatocellular carcinoma via targeting the PRMT1-SREBF1 axis-mediated lipid metabolism.
Yuehua Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.